Mariam Obaji

Mariam Obaji

Auto-generated profile, based on publicly available information

Mariam Obaji

Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2025 in Science Advances
Verified
Journal Article
Open access
MMMacy Mora-Antoinette
Macy Mora-Antoinette
AGAndrea Garcia-Ortiz
Andrea Garcia-Ortiz
MOMariam Obaji
Mariam Obaji
ASAlexander Saffari
Alexander Saffari
Melia Doyas MatthewsMelia Doyas Matthews
Melia Doyas Matthews
KLKarl J. Lewis
Karl J. Lewis
Recent evidence suggests that acetylcholine has a positive influence on bone mechanotransduction. Osteocytes express components for nicotinic acetylcholine receptors (nAChRs), which are known for mediating calcium signaling and may affect mechanosensitivity. Here, we use fluorescent imaging approaches to provide evidence of close spatial association between osteocytes and cholinergic nerve fibers in cortical bone in vivo. Moreover, we show that osteocytes are responsive to cholinergic signaling, influencing bone mechanoadaptation. We report sexually dimorphic patterns in bone structure and mechanobiology based on nAChR function. In females, osteocyte mechanosensitivity was decreased at small force magnitudes and tissue level deficits were recovered with anabolic loading. In males, osteocyte mechanosensitivity was increased in some groups and anabolic loading had very little effect on overall tissue architecture. This work establishes a previously unidentified paradigm wherein osteocytes interface with cholinergic nerves and bone mechanotransduction is regulated by osteocyte cholinergic signaling in a sexually dimorphic way.

31 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
NGNicole R. Gould
Nicole R. Gould
ACAndre F. Coello
Andre F. Coello
JMJennifer A. McKenzie
Jennifer A. McKenzie
TLTiandao Li
Tiandao Li
Katherine HixonKatherine Hixon
Katherine Hixon
MSMatthew J. Silva
Matthew J. Silva
Fractures heal by rapid formation of mineralized callus. Essential to this process is proliferation of periosteal cells to supply bone-forming osteoblasts. To better understand the role of cell proliferation in fracture healing, we asked: How is callus composition altered when osteolineage cells proliferation is blocked? Do mature osteoblasts proliferate to contribute to callus formation? First, mice expressing herpes simplex virus-thymidine kinase (HSV-TK) driven by the 3.6Col1a1 promoter were treated with ganciclovir (GCV) to ablate proliferating osteolineage cells for 5 or 10 days. Analysis of callus cells using single-cell RNA-seq revealed that GCV-treated Col1-TK mice had fewer osteoblasts and chondrocytes than control mice, with more myofibroblasts and immune cells, consistent with fibrous nonunion. In controls, 15-30% of callus cells that expressed the early osteoblast markers osterix (OSX) and the late marker osteocalcin (OCN) were in the cell cycle. Next, we targeted proliferating osteoblasts at different stages of differentiation by crossing Osx-CreERT2, Ocn-Cre and Dmp1-CreERT2 mice with novel ROSA-TK mice. Following fracture, each Cre;ROSA-TK mouse line exhibited poorer radiographic healing, decreased callus bone volume and a shift from callus bone to fibrous tissue. We conclude that osteoblasts, often considered post-mitotic, proliferate after fracture to contribute to formation of mineralized callus essential to healing.

19 November 2026 in bioRxiv
Verified
Preprint
Open access
LCLeyi Chen
Leyi Chen
YKYu Seon Kim
Yu Seon Kim
Katherine HixonKatherine Hixon
Katherine Hixon
NGNicole Gould
Nicole Gould
ACAndre Coello
Andre Coello
MSMatthew Silva
Matthew Silva
Nonunions occur in 5-10% of fracture patients, and current treatments are expensive with variable success. Controllable, localized delivery of BMP2 using porous, degradable scaffolds may be a promising alternative. We designed tube-shaped cryogel scaffolds (chitosan-gelatin, CG; chitosan-agarose-gelatin, CAG) to deliver a doxycycline-inducible BMP2-lentivirus vector (BMP2-LV). Results showed that CAG scaffolds have larger pores, higher toughness, and better cell infiltration than CG scaffolds. When scaffolds were implanted subcutaneously in mice and treated with continuous doxycycline, x-ray radiographs and microCT showed mineralization in scaffolds seeded with adipose-derived stem cells (BMP2-LV-ASC) but not acellular scaffolds (BMP2-LV) 4-weeks after implantation. Scaffolds that were implanted at the site of an established femoral nonunion 4-weeks after fracture and treated with continuous doxycycline showed improved healing with CG/CAG BMP2-LV and BMP2-LV-ASC compared to scaffold-only controls. At 2-weeks post implantation, microCT and histology showed that BMP2-expressing scaffolds promoted increased callus mineralization relative to scaffold-only. At 8-weeks post implantation, microCT and histology showed near-complete bone bridging in BMP2-treated groups compared to still visible fracture lines in the scaffold-only groups. However, CG/CAG BMP2-LV-ASC groups also showed heterotopic ossification. Finally, we demonstrated that heterotopic ossification was eliminated at 8-weeks post implantation in CG BMP2-LV-ASC groups by restricting doxycycline treatment to the first 3 days after implantation. We conclude that lentiviral BMP2 delivery using cellularized and acellular cryogel scaffolds enhanced fracture healing in a nonunion model, and that a 3-day period of BMP2 induction using an inducible system was sufficient to promote healing without the complication of heterotopic ossification.